|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
2001 Market Street, Suite 3915, Unit 15, Philadelphia, Pennsylvania 19103, US
|
|
Context Therapeutics Inc. (Nasdaq: CNTX) is a biopharmaceutical company committed to advancing medicines for solid tumors. Context is developing CTIM-76, a selective Claudin 6 (CLDN6) x CD3 bispecific antibody for CLDN6-positive tumors, currently in preclinical development. Context is headquartered in Philadelphia. For more information, visit www.contexttherapeutics.com.
|
Context Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
100%
|
The widely used Context Therapeutics email format is {f}{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Context Therapeutics customer service number in your country click here to find.
Martin Lehr is the CEO of Context Therapeutics. To contact Martin Lehr email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.